BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee SC, Tan HT, Chung MCM. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2014; 20(12): 3112-3124 [PMID: 24696598 DOI: 10.3748/wjg.v20.i12.3112]
URL: https://www.wjgnet.com/1948-5182/full/v20/i12/3112.htm
Number Citing Articles
1
Hanaa Hibishy Gaballah, Soha Said Zakaria, Saber Abdelrahman Ismail. Activity and Expression Pattern of NF-κB/P65 in Peripheral Blood from Hepatocellular Carcinoma Patients - Link to Hypoxia Inducible Factor -1αAsian Pacific Journal of Cancer Prevention 2014; 15(16): 6911 doi: 10.7314/APJCP.2014.15.16.6911
2
Fan-Di Meng, Ji-Chao Wei, Kai Qu, Zhi-Xin Wang, Qi-Fei Wu, Ming-Hui Tai, Hao-Chen Liu, Rui-Yao Zhang, Chang Liu. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(1): 196-213 doi: 10.3748/wjg.v21.i1.196
3
Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang, Jia-Hui Lin, Wen-Shu Chen, Woei-Cherng Shyu, Han-Chieh Wu, Cheng-Yuan Peng, Ih-Jen Su, Long-Bin Jeng. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma RecurrenceViruses 2020; 12(8): 796 doi: 10.3390/v12080796
4
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. Expression, clinicopathologic and prognostic significance of plasminogen activator inhibitor 1 in hepatocellular carcinomaCancer Biomarkers 2020; 27(3): 285 doi: 10.3233/CBM-190560
5
Daniel Shouval, Scott L. Friedman. Focusing on the past, present, and future of hepatologyJournal of Hepatology 2014; 61(6): 1196 doi: 10.1016/j.jhep.2014.08.039
6
Matthias Ocker. Biomarkers for hepatocellular carcinoma: What’s new on the horizon?World Journal of Gastroenterology 2018; 24(35): 3974-3979 doi: 10.3748/wjg.v24.i35.3974
7
Xiaonian Zhu, Meng Yan, Wei Luo, Wei Liu, Yuan Ren, Chunhua Bei, Guifang Tang, Ruiling Chen, Shengkui Tan. Expression and clinical significance of PcG-associated protein RYBP in hepatocellular carcinomaOncology Letters 2017; 13(1): 141 doi: 10.3892/ol.2016.5380
8
Olivier Fernandez, Maria Urrutia, Stéphane Bernillon, Catherine Giauffret, François Tardieu, Jacques Le Gouis, Nicolas Langlade, Alain Charcosset, Annick Moing, Yves Gibon. Fortune telling: metabolic markers of plant performanceMetabolomics 2016; 12(10) doi: 10.1007/s11306-016-1099-1
9
Chiao-Fang Teng, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular CarcinomaViruses 2020; 12(9): 945 doi: 10.3390/v12090945
10
Huan-Hsien Kuo, Ruey-Jen Lin, Jung-Tung Hung, Chung-Bao Hsieh, Tsai-Hsien Hung, Fei-Yun Lo, Ming-Yi Ho, Chau-Ting Yeh, Yen-Lin Huang, John Yu, Alice L. Yu. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11136-w
11
Xiuchao Wang, He Ren, Tiansuo Zhao, Jing Chen, Wei Sun, Yan Sun, Weidong Ma, Jian Wang, Chuntao Gao, Song Gao, Mingxiao Lang, Li Jia, Jihui Hao. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resectionCarcinogenesis 2014; 35(10): 2283 doi: 10.1093/carcin/bgu162
12
Shu Shen, Junjie Kong, Yiwen Qiu, Xianwei Yang, Wentao Wang, Lvnan Yan. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysisJournal of Cellular Biochemistry 2019; 120(6): 10069 doi: 10.1002/jcb.28290
13
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinomaPathology 2020; 52(3): 359 doi: 10.1016/j.pathol.2020.01.436
14
G.J. Wengert, H. Bickel, J. Breitenseher, A. Ba-Ssalamah. Primäre LebertumorenDer Radiologe 2015; 55(1): 27 doi: 10.1007/s00117-014-2705-8
15
Youfu Zhang, Xuyang Wang, Huaxiang Wang, Yi Jiang, Zhidan Xu, Laibang Luo. Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.893107
16
Chenghua Cui, Zheming Lu, Liu Yang, Yanhong Gao, Wei Liu, Liankun Gu, Chen Yang, James Wilson, Zhiqian Zhang, Baocai Xing, Dajun Deng, Zhong Sheng Sun. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomasMolecular Carcinogenesis 2016; 55(7): 1163 doi: 10.1002/mc.22359
17
H.Z. Dundar, F. Aksoy, S. Ak Aksoy, P. Tasar, N. Ugras, B. Tunca, U. Egeli, G. Cecener, O. Yerci, E. Kaya. Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus–Mediated Hepatocellular Carcinoma Undergoing Liver TransplantationTransplantation Proceedings 2019; 51(4): 1157 doi: 10.1016/j.transproceed.2019.01.089
18
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinomaPeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
19
Yongxin Zhang, Xiaofei Lv, Jiliang Qiu, Bin Zhang, Lu Zhang, Jin Fang, Minmin Li, Luyan Chen, Fei Wang, Shuyi Liu, Shuixing Zhang. Deep Learning With 3D Convolutional Neural Network for Noninvasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma Journal of Magnetic Resonance Imaging 2021; 54(1): 134 doi: 10.1002/jmri.27538
20
Franziska Mußbach, Petra Henklein, Martin Westermann, Utz Settmacher, Frank-D. Böhmer, Roland Kaufmann. Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivationJournal of Cancer Research and Clinical Oncology 2015; 141(5): 813 doi: 10.1007/s00432-014-1863-4
21
Ching-Feng Weng, Max K. Leong. Advances in Molecular Toxicology 2019; 13: 31 doi: 10.1016/B978-0-444-64293-6.00002-6
22
Jiang Chen, Jie Zhao, Rui Ma, Hui Lin, Xiao Liang, Xiujun Cai, Kwan Man. Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-AnalysisPLoS ONE 2014; 9(8): e103952 doi: 10.1371/journal.pone.0103952
23
Bo Li, Aixia Liu, Yi Wen, Guang Yang, Jing Zhao, Xiaohan Li, Yuanli Mao, Boan Li. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world dataJournal of Clinical Laboratory Analysis 2021; 35(9) doi: 10.1002/jcla.23932
24
Andrew Gabrielson, Yunan Wu, Hongkun Wang, Jiji Jiang, Bhaskar Kallakury, Zoran Gatalica, Sandeep Reddy, David Kleiner, Thomas Fishbein, Lynt Johnson, Eddie Island, Rohit Satoskar, Filip Banovac, Reena Jha, Jaydeep Kachhela, Perry Feng, Tiger Zhang, Anteneh Tesfaye, Petra Prins, Christopher Loffredo, John Marshall, Louis Weiner, Michael Atkins, Aiwu Ruth He. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCCCancer Immunology Research 2016; 4(5): 419 doi: 10.1158/2326-6066.CIR-15-0110
25
Feng Wang, Hou-Qun Ying, Bang-Shun He, Yu-Qin Pan, Qi-Wen Deng, Hui-Ling Sun, Jie Chen, Xian Liu, Shu-Kui Wang. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathwayOncotarget 2015; 6(10): 7899 doi: 10.18632/oncotarget.3219
26
Guido Torzilli, Matteo Donadon, Jacques Belghiti, Norihiro Kokudo, Tadatoshi Takayama, Alessandro Ferrero, Gennaro Nuzzo, Jean-Nicolas Vauthey, Michael A. Choti, Eduardo De Santibanes, Masatoshi Makuuchi. Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma: a Novel Nomogram from the “HCC East & West Study Group”Journal of Gastrointestinal Surgery 2016; 20(6): 1154 doi: 10.1007/s11605-016-3132-0
27
Chao Guo, Shuhuang Zhou, Weimin Yi, Pingzhou Yang, Ou Li, Jianming Liu, Chuang Peng. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinomaExperimental and Molecular Pathology 2021; 120: 104638 doi: 10.1016/j.yexmp.2021.104638
28
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resectionFuture Oncology 2022; 18(26): 2903 doi: 10.2217/fon-2021-1558
29
Jinxia Liu, Guijuan Zong, Chengliang Zhang, Chunsun Li, Xudong Chen, Yixin Zhang. Anxiety and serum catecholamines as predictors of survival and recurrence in hepatocellular carcinomaPsycho-Oncology 2017; 26(9): 1347 doi: 10.1002/pon.4305
30
Zhongyi Guo, Hui Shi, Chunlei Li, Yuanyuan Luo, Sixue Bi, Rongmin Yu, Haoran Wang, Wanying Liu, Jianhua Zhu, Weijuan Huang, Liyan Song. Identification and Characterization of a Novel Protein ASP-3 Purified from Arca subcrenata and Its Antitumor MechanismMarine Drugs 2019; 17(9): 528 doi: 10.3390/md17090528
31
Xiao-Pin Ma, Guopeng Yu, Xubo Chen, Qianyi Xiao, Zhuqing Shi, Lu-Yao Zhang, Haitao Chen, Pengyin Zhang, Dong-Lin Ding, Hui-Xing Huang, Hexige Saiyin, Tao-Yang Chen, Pei-Xin Lu, Neng-Jin Wang, Hongjie Yu, Carly Conran, Jielin Sun, S. Lilly Zheng, Jianfeng Xu, Long Yu, De-Ke Jiang. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinomaTumor Biology 2016; 37(7): 9931 doi: 10.1007/s13277-016-4897-1
32
Limin Ma, Changming Tao, Yingying Zhang, Enas Abdulhay. MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT PathwayJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/7026174
33
Ai-Hua Tong, Juan Tan, Jin-Hua Zhang, Fang-Jiang Xu, Fu-Yuan Li, Chun-Yu Cao. Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathwayJournal of Biochemical and Molecular Toxicology 2019; 33(2): e22241 doi: 10.1002/jbt.22241
34
Jie Cai, Xuehua Sun, Han Guo, Xiaoye Qu, Hongting Huang, Chang Yu, Hailong Wu, Yueqiu Gao, Xiaoni Kong, Qiang Xia. Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinomaOncogenesis 2020; 9(12) doi: 10.1038/s41389-020-00287-7
35
Bin Qiu, Meng-Fei Zhao, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Shan Dai, Jian-Nan Yao, Fu-Quan Liu. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertensionWorld Journal of Gastroenterology 2015; 21(43): 12439-12447 doi: 10.3748/wjg.v21.i43.12439
36
Xiuli Mu, Xi Wang, Yan Wei, Chaochao Wen, Qi Zhang, Chunyang Xu, Chang Liu, Chan Zhang, Fanxiu Meng, Na Zhao, Tao Gong, Rui Guo, Gongqin Sun, Gaopeng Li, Hongwei Zhang, Qin Qin, Jun Xu, Xiushan Dong, Lumei Wang, Baofeng Yu. ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinomaCancer Gene Therapy 2020; 27(10-11): 754 doi: 10.1038/s41417-019-0145-3
37
Chun-Peng Yu, Shui Yu, Lei Shi, Song Wang, Zi-Xiang Li, Yan-Hua Wang, Cheng-Jian Sun, Jun Liang. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1Molecular Medicine Reports 2017; 16(4): 5181 doi: 10.3892/mmr.2017.7223
38
Heng-Yuan Hsu, Ming-Chin Yu, Chao-Wei Lee, Hsin-I Tsai, Chang-Mu Sung, Chun-Wei Chen, Shu-Wei Huang, Cheng-Yu Lin, Wen-Juei Jeng, Wei-Chen Lee, Miin-Fu Chen. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinomaBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3748-9
39
Xiaonian Zhu, Guangzi Qi, Cong Li, Chunhua Bei, Chao Tan, Ying Zhang, Wenxiang Shi, Wen Zeng, Juan Kong, Yuanyuan Fu, Shengkui Tan. Expression and Clinical Significance of CMTM6 in Hepatocellular CarcinomaDNA and Cell Biology 2019; 38(2): 193 doi: 10.1089/dna.2018.4513
40
Wei Song, Jingjing Zhang, Jianbo Zhang, Miaomiao Sun, Qingxin Xia. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cellsCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0857-3
41
Haixia Lin, Laura E. Ewing, Igor Koturbash, Bill J. Gurley, Isabelle R. Miousse. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospectsFood and Chemical Toxicology 2017; 110: 229 doi: 10.1016/j.fct.2017.10.026
42
Jianfei Tu, Zhongwei Zhao, Min Xu, Minjiang Chen, Qiaoyou Weng, Jiangmei Wang, Jiansong Ji. Retracted : LINC00707 contributes to hepatocellular carcinoma progression via sponging miR‐206 to increase CDK14 Journal of Cellular Physiology 2019; 234(7): 10615 doi: 10.1002/jcp.27737
43
Bo Liang, Chunhong Jia, Yu Huang, Hua He, Jialu Li, Hui Liao, Xiao Liu, Xincheng Liu, Xiaochun Bai, Dinghua Yang. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMTDigestive Diseases and Sciences 2015; 60(8): 2360 doi: 10.1007/s10620-015-3730-9
44
Wujun Li, Shaobo Zhang. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma CellsOncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(2): 285 doi: 10.3727/096504016X14732523471442
45
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapyJournal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
46
Wei Yuan, Maowei Yang, Yue Zhu. Development and validation of a gene signature predicting the risk of postmenopausal osteoporosisBone & Joint Research 2022; 11(8): 548 doi: 10.1302/2046-3758.118.BJR-2021-0565.R1
47
Lanjing Zhang. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 95 doi: 10.1007/978-3-319-68082-8_6
48
Jifei Wang, Dasheng Wu, Meili Sun, Zhenpeng Peng, Yingyu Lin, Hongxin Lin, Jiazhao Chen, Tingyu Long, Zi-Ping Li, Chuanmiao Xie, Bingsheng Huang, Shi-Ting Feng. Deep Segmentation Feature-Based Radiomics Improves Recurrence Prediction of Hepatocellular CarcinomaBME Frontiers 2022; 2022: 1 doi: 10.34133/2022/9793716
49
Yong-Rong Liang, Zhe Guo, Jing-Hang Jiang, Bang-De Xiang, Le-Qun Li. Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled studyOncology Letters 2016; 12(5): 3513 doi: 10.3892/ol.2016.5121
50
Cunhua Shao, Gongpan Liu, Xiaobin Zhang, Anyun Li, Xingjun Guo. <p>Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766</p>OncoTargets and Therapy 2020; : 3013 doi: 10.2147/OTT.S243736
51
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanismsHepatology International 2019; 13(2): 180 doi: 10.1007/s12072-018-9920-8
52
Lei Zhang, Martin H. Bluth, Amarpreet Bhalla. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary TractClinics in Laboratory Medicine 2018; 38(2): 367 doi: 10.1016/j.cll.2018.03.003
53
Xi Ma, Lin Zhou, Shusen Zheng. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinomaPeerJ 2020; 8: e8930 doi: 10.7717/peerj.8930
54
Guifang Yu, Jieheng Lin, Chengcheng Liu, Kailian Hou, Min Liang, Boyun Shi. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosisScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16781-9
55
Krizia Pocino, Cecilia Napodano, Mariapaola Marino, Riccardo Di Santo, Luca Miele, Nicoletta De Matthaeis, Francesca Gulli, Raffaele Saporito, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile. A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular CarcinomaCancers 2021; 14(1): 11 doi: 10.3390/cancers14010011
56
Aline M. A. Martins, J. Huygens P. Garcia, Marcos N. Eberlin. Mass Spectrometry as a Clinical Integrative Tool to Evaluate Hepatocellular Carcinoma: Moving to the MainstreamExpert Review of Gastroenterology & Hepatology 2019; 13(9): 821 doi: 10.1080/17474124.2019.1651643
57
Brian I. Shaw, Aaron Lucander, Kadiyala V. Ravindra. Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and ManagementTransplantation Direct 2019; 5(9): e483 doi: 10.1097/TXD.0000000000000921
58
Xin Song, Shidong Zhang, Run Tian, Chuanjun Zheng, Yuge Xu, Tianxian Wang, Chunhua Bei, Huixia Zhang, Xiao He, Xiaonian Zhu, Shengkui Tan. Expression and clinical significance of CMTM1 in hepatocellular carcinomaOpen Medicine 2021; 16(1): 217 doi: 10.1515/med-2021-0221
59
Binkui Li, Pinzhu Huang, Jiliang Qiu, Yadi Liao, Jian Hong, Yunfei Yuan. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosisMedical Oncology 2014; 31(10) doi: 10.1007/s12032-014-0230-2